Gynecologic Oncology | Addressing Current Questions and Emerging Considerations with the Use of PARP Inhibitors in the Management of Ovarian Cancer
Manage episode 236376165 series 1464352
Faculty presentations from an independent satellite symposium during the Society of Gynecologic Oncology’s 2019 Annual Meeting on Women’s Cancer. Featuring perspectives from Dr Robert L Coleman, Prof Jonathan A Ledermann, Dr Stephanie Lheureux and Dr Kathleen Moore:
- Genomic Testing and Management of Primary Ovarian Cancer — Dr Moore (00:00)
- Role of PARP Inhibition in the Management of Relapsed Ovarian Cancer — Prof Ledermann (10:37)
- Prevention, Recognition and Management of PARP Inhibitor-Associated Side Effects — Dr Coleman (21:04)
- Investigational Applications of Approved PARP Inhibitors; Other PARP Inhibitors in Clinical Development — Dr Lheureux (29:33)
2168 episodes available. A new episode about every 0 hours averaging 70 mins duration .